79322105 - ADAC

Information

  • Trademark
  • 79322105
  • Serial Number
    79322105
  • Registration Number
    6970291
  • Filing Date
    August 24, 2021
    3 years ago
  • Registration Date
    February 07, 2023
    a year ago
  • Transaction Date
    May 30, 2023
    a year ago
  • Status Date
    February 07, 2023
    a year ago
  • Published for Opposition Date
    November 22, 2022
    a year ago
  • Location Date
    February 07, 2023
    a year ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    HAN, DAWN L
  • Attorney Docket Number
    DJB/2739-241
    Attorney Name
    Donna J. Bunton
    Law Office Assigned Location Code
    L70
  • Owners
Mark Drawing Code
4000
Mark Identification
ADAC
Case File Statements
  • GS0051: Pharmaceutical preparations for human use for the treatment and prevention of diseases and conditions in the areas of immunology, oncology, immune-oncology, diabetes, autoimmunology, dermatology, gynecology, urology, gastroenterology and ophthalmology; veterinary preparations for the treatment and prevention of diseases and conditions in the areas of immunology, oncology, immune-oncology, diabetes, autoimmunology, dermatology, gynecology, urology, gastroenterology and ophthalmology; vaccines; therapeutic medicines for the treatment and prevention of diseases and conditions in the areas of immunology, oncology, immune-oncology, diabetes, autoimmunology, dermatology, gynecology, urology, gastroenterology and ophthalmology; pharmaceutical preparations for the treatment of diseases and conditions in the areas of immunology, oncology, immuno-oncology, diabetes, autoimmunology, dermatology, gynecology, urology, gastroenterology and ophthalmology; therapeutic antibodies for the treatment and prevention of diseases and conditions in the areas of immunology, oncology, immune-oncology, diabetes, autoimmunology, dermatology, gynecology, urology, gastroenterology and ophthalmology
  • GS0011: Chemicals for use in industry for production of antibodies and synthetic and natural peptides
  • GS0101: Delivery systems in the nature of implantable drug delivery ports for the deferred, controlled or immediate release of active substances of pharmaceutical preparations; inhalers for medical use; syringes for injection and medical purposes
  • GS0421: Research and development within the biological, pharmacological, veterinary, microbiological, biomedical, pharmabiotical, biotherapeutical and biotechnological areas; research and development of new products featuring a synthetic antibody library including methods for selection and screening of such; research and development in the area of personalized medicine; medical laboratory services related to production of antibodies; research and development in the area of antibodies
Case File Event Statements
  • 5/30/2023 - a year ago
    28 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 5/8/2023 - a year ago
    27 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 5/8/2023 - a year ago
    26 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 5/7/2023 - a year ago
    25 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 2/7/2023 - a year ago
    24 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 2/7/2023 - a year ago
    23 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 11/22/2022 - a year ago
    22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 11/22/2022 - a year ago
    21 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 11/2/2022 - 2 years ago
    20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 10/28/2022 - 2 years ago
    19 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 10/17/2022 - 2 years ago
    18 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/25/2022 - 2 years ago
    17 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 7/25/2022 - 2 years ago
    16 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 7/25/2022 - 2 years ago
    15 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 7/25/2022 - 2 years ago
    14 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 5/31/2022 - 2 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/31/2022 - 2 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 5/31/2022 - 2 years ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/11/2022 - 2 years ago
    10 - REFUSAL PROCESSED BY IB Type: RFNT
  • 3/18/2022 - 2 years ago
    9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 3/18/2022 - 2 years ago
    8 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 2/17/2022 - 2 years ago
    7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 2/16/2022 - 2 years ago
    6 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/7/2022 - 2 years ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/11/2021 - 2 years ago
    4 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 10/16/2021 - 3 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 10/12/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 10/8/2021 - 3 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR